Status:

UNKNOWN

The Effect of Dexmedetomidine on Kidney Perfusion in Paediatric Patients

Lead Sponsor:

Mai Madkour

Conditions:

Congenital Heart Disease

Eligibility:

All Genders

6-12 years

Phase:

PHASE2

Brief Summary

I. Study design: open/ blinded randomized, controlled study. II. Study setting and location: The study will be conducted in Abul Reesh Paediatric Hospital Faculty of Medicine /Cairo University from ...

Eligibility Criteria

Inclusion

  • children 6m to 12 years complex congenital heart disease

Exclusion

  • signifiacnt ventricular dysfunction pre-existing CNS disorders

Key Trial Info

Start Date :

May 20 2017

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

July 20 2018

Estimated Enrollment :

40 Patients enrolled

Trial Details

Trial ID

NCT03425734

Start Date

May 20 2017

End Date

July 20 2018

Last Update

February 8 2018

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Pediatric University Hospitals

Cairo, Outside US and Canada, Egypt, 12555

The Effect of Dexmedetomidine on Kidney Perfusion in Paediatric Patients | DecenTrialz